BioDelivery Sciences drug wins European approval

BioDelivery Sciences drug wins European approval
BioDelivery Sciences International said this morning that its oral pain patch for cancer patients has been approved for the European market.
Read more on The News & Observer

Hyperion Therapeutics Receives FDA Fast Track Designation For Glycerol Phenylbutyrate For The Treatment Of Urea Cycle …
Hyperion Therapeutics, Inc. announced that its investigational compound glycerol phenylbutyrate (HPN-100) has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) as adjunctive therapy for the chronic management of urea cycle disorders. Hyperion recently completed its phase III trial which was conducted under a Special Protocol Assessment (SPA) agreement with the …
Read more on Medical News Today